| European Case Law Identifier: | ECLI:EP:BA:2008:T085706.20080605 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 05 June 2008 | ||||||||
| Case number: | T 0857/06 | ||||||||
| Application number: | 90109337.7 | ||||||||
| IPC class: | C12P 21/02 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Tumor necrosis factor binding protein II, its purification and antibodies thereto | ||||||||
| Applicant name: | YEDA RESEARCH AND DEVELOPMENT CO., LTD. | ||||||||
| Opponent name: | ABBOTT GmbH & Co. KG | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Presence of assistant at deliberations (yes) Appealability of interlocutory decision (yes) Added subject-matter (no) Sufficiency of disclosure (yes) Novelty (yes) |
||||||||
| Catchwords: |
1. The discretion under Article 19(1), second sentence, RPBA may be exercised to allow the board's assistant to attend and to take part in the deliberations (see points 1 to 6). 2. A first interlocutory decision which does not allow a separate appeal can be appealed together with a second interlocutory decision which does not leave any substantive issues outstanding and which allows a separate appeal (see points 7 to 11). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t060857eu1.html
Date retrieved: 17 May 2021